Medicinal Cannabis Matters: Friday Roundup - 28 November 2025
As we approach the end of Medicinal Cannabis Awareness Month, this week brings a set of developments that highlight just how much progress is being made across clinical education, patient safety and scientific understanding. From tackling misconceptions in primary care to advancing dosing standards and exploring new evidence on cancer risk, the sector continues to move forward with clarity and purpose.
Bridging the Knowledge Gap on Medicinal Cannabis
A new feature from Cannabis Health News highlights the important effort to correct outdated assumptions within general practice for medicinal cannabis use.
This interview highlights a barrier many patients still face: GPs who are uncertain to engage in conversations about medicinal cannabis due to limited training or exposure to evidence.
This article makes it clear that the narrative needs to be shifted from caution based on unfamiliarity to confidence based on data. It emphasises the safety profile of controlled, prescribed cannabis-based medicines, the growing evidence base behind chronic pain, neurological and psychiatric conditions and the importance of collaborative care between GPs and specialist prescribers and clinics, like Medicann.
Medicinal cannabis is not an alternative “last resort”, but a clinically supervised option that deserves informed, evidence-led discussion.
A Landmark Moment for Medicinal Cannabis in the UK
In a significant step forward for patient safety and consistency, the Medical Cannabis Clinicians Society (MCCS) has released a major new comprehensive dosing handbook for medical cannabis oil. Read more here.
The guide offers structured dosing protocols, clear titration pathways, safety considerations and evidence-backed ranges tailored to specific conditions.
For prescribers, this provides a framework that can reduce variability and support clinical confidence. For patients, it represents a more predictable and transparent treatment experience.
Standardisation is a major milestone for the sector, and publications like this lay the groundwork for better outcomes and improved trust in medicinal cannabis.
Cannabis Health Symposium 2025: Key Takeaways
The latest report from the Cannabis Health Symposium 2025 continues to showcase the innovation and collaboration taking place within the UK medicinal cannabis space.
With deeper insights into the endocannabinoid system and its therapeutic potential, a renewed focus on patient-centred care and quality-of-life improvements, discussions around education gaps in healthcare and the growing importance of real-world evidence in shaping future prescribing frameworks, these conversations are paving the way for more integrated services and more confident healthcare engagement across the UK.
Throughout November, Medicann has been proud to highlight the evidence, personal stories and clinical advancements that continue to move medicinal cannabis into the mainstream. Medicinal Cannabis Awareness Month has underscored one key truth: when patients are supported, informed and empowered, outcomes improve.
If this month has prompted you to consider whether medicinal cannabis could support your health or wellbeing, the first step is simple. You can check your eligibility quickly and confidentially online, no matter where you live in the UK or Channel Islands.
Explore your eligibility today and take the first step towards safe, specialist-led care.
Disclaimer: This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.